Next generation cancer therapy: PD-1/PD-L1 blockade in ovarian cancers

被引：0
|
作者：
Hamanishi, J. [1 ]
Mandai, M. [2 ]
Matsumura, N. [1 ]
Abiko, K. [1 ]
Baba, T. [1 ]
Yamaguchi, K. [1 ]
Konishi, I. [1 ]
机构：
[1] Kyoto Univ, Kyoto, Japan
[2] Kinki Univ, Osaka, Japan
来源：
JOURNAL OF REPRODUCTIVE IMMUNOLOGY | 2015年 / 112卷
关键词：
D O I：
10.1016/j.jri.2015.09.071
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [41] SIGNIFICANCE OF PD-1 AND PD-L1 EXPRESSION IN OVARIAN CANCER BIOLOGY
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Giridhar, S.
    Wenzel, S.
    Sprung, S.
    Lax, S.
    Zeimet, A.
    Fiegl, H.
    Marth, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1714 - 1714
  • [42] The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients
    Pawlowska, Anna
    Skiba, Wiktoria
    Suszczyk, Dorota
    Kurylo, Weronika
    Jakubowicz-Gil, Joanna
    Paduch, Roman
    Wertel, Iwona
    CANCERS, 2022, 14 (23)
  • [43] Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
    Wu, Bogang
    Sun, Xiujie
    Gupta, Harshita B.
    Yuan, Bin
    Li, Jingwei
    Ge, Fei
    Chiang, Huai-Chin
    Zhang, Xiaowen
    Zhang, Chi
    Zhang, Deyi
    Yang, Jing
    Hu, Yanfen
    Curiel, Tyler J.
    Li, Rong
    ONCOIMMUNOLOGY, 2018, 7 (11):
  • [44] Phytochemicals in regulating PD-1/PD-L1 and immune checkpoint blockade therapy
    Zhang, Qi
    Yang, Chenying
    Gao, Xingsu
    Dong, Ju
    Zhong, Caiyun
    PHYTOTHERAPY RESEARCH, 2024, 38 (02) : 776 - 796
  • [45] Predictive biomarkers for PD-1 and PD-L1 immune checkpoint blockade therapy
    Song, Yue
    Li, Zhaoming
    Xue, Weili
    Zhang, Mingzhi
    IMMUNOTHERAPY, 2019, 11 (06) : 515 - 529
  • [46] Combination of PD-1/PD-L1 checkpoint blockade and dendritic cell therapy
    Nesselhut, J.
    Marx, D.
    Lange, H.
    Chang, R. Y.
    Nesselhut, T.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 : 95 - 95
  • [47] COMBINING PD-1/PD-L1 BLOCKADE AND RANKL INHIBITORS TO TREAT BREAST CANCERS UNRESPONSIVE TO STANDARD THERAPY
    Pilard, C.
    Roncarati, P.
    Hendrick, E.
    Lebeau, A.
    Bruyere, D.
    Lerho, T.
    Ancion, M.
    Reynders, C.
    Delvenne, P.
    Herfs, M.
    Hubert, P.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A50 - A51
  • [48] Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade
    Zhang, Min
    Liu, Kehai
    Wang, Mingfu
    RSC ADVANCES, 2019, 9 (58) : 33903 - 33911
  • [49] PD-1/PD-L1 blockade in cervical cancer: current studies and perspectives
    Wang, Yumeng
    Li, Guiling
    FRONTIERS OF MEDICINE, 2019, 13 (04) : 438 - 450
  • [50] PD-1/PD-L1 Blockade Accelerates the Progression of Atherosclerosis in Cancer Patients
    Dong, Mei
    Yu, Ting
    Tse, Gary
    Lin, Zerun
    Lin, Chen
    Zhang, Nan
    Wang, Rujian
    Liu, Tong
    Zhong, Lin
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (03) : 1 - 20
12345